Highlights
- Third quarter fiscal 2026 sales were $817.7 million, compared with $741.5 million, and Net Income was $152.8 million.
- Diluted earnings per share were $2.73 for the third quarter and $7.20 for the nine months ended July 31, 2026.
- Net cash provided by Operating Activities for the nine months was $570.5 million, compared with $516.3 million a year earlier.
- Nordson repaid $258 million of debt, repurchased $159 million of shares and paid $137 million in dividends over nine months.
Nordson Corporation (NASDAQ:NDSN) shares were trading at USD 310.27 on November 20, 2026, down 2.06%, with a relative Volume at time of 2.77. The precision dispensing and fluid management company filed its Quarterly Report for the third quarter of fiscal 2026, which ended July 31, 2026, on August 20, 2026.
Nordson is an Ohio corporation with principal executive offices in Westlake, Ohio. It reports three operating segments: Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solutions. The company delivers proprietary dispensing and processing technology, fluid management components for medical and industrial uses, and products for electronics production, measurement and control. Its fiscal year ends on October 31.
Third Quarter Fiscal 2026 Results
For the three months ended July 31, 2026, sales were $817.7 million, compared with $741.5 million in the prior-year quarter. Cost of sales was $363.9 million, compared with $335.0 million. Selling and administrative expenses were $230.6 million, compared with $206.5 million. Gross margins were 55.5 percent, compared with 54.8 percent.
Operating profit was $223.1 million, compared with $187.8 million. Interest expense was $20.8 million, compared with $26.3 million. Net income was $152.8 million, compared with $125.8 million. Basic Earnings Per Share were $2.74, compared with $2.23, and Diluted Earnings per Share were $2.73, compared with $2.22. Total comprehensive income was $129.4 million, compared with $131.0 million.
Segment Results
Industrial Precision Solutions sales were $367.2 million, compared with $350.8 million, with Organic Sales up 3.3 percent. Segment EBITDA was $129.9 million, or 35.4 percent of sales, compared with $130.1 million, or 37.1 percent. The company said segment EBITDA decreased 170 basis points despite higher sales due to continued Investment in innovation and select near-term inflationary pressures.
Medical and Fluid Solutions sales were $230.5 million, compared with $219.5 million, with organic sales up 10.6 percent. Segment EBITDA was $88.3 million, or 38.3 percent of sales, compared with $83.2 million, or 37.9 percent.
Advanced Technology Solutions sales were $219.9 million, compared with $171.3 million, with organic sales up 30.9 percent. Segment EBITDA was $65.7 million, or 29.9 percent of sales, compared with $41.5 million, or 24.3 percent. Total segment EBITDA was $283.9 million, compared with $254.8 million.
By region, third quarter sales were $331.5 million in the Americas, $192.4 million in Europe and $293.8 million in Asia Pacific.
Nine-Month Results, Cash Flow and Balance Sheet
For the nine months ended July 31, 2026, sales were $2.23 billion, compared with $2.04 billion. Operating profit was $586.7 million, compared with $497.5 million, and net income was $403.5 million, compared with $332.8 million. Dividends declared were $0.82 per share in each fiscal quarter of 2026, compared with $0.78 per share a year earlier.
Net cash provided by operating activities was $570.5 million, compared with $516.3 million. Additions to property, plant and equipment were $40.3 million, and acquisitions of businesses, net of cash acquired, were $11.6 million. Net cash used in financing activities was $510.7 million, compared with $444.5 million, including net repayment of long-term Debt of $450.0 million, Short-Term Debt proceeds of $192.0 million, dividends paid of $137.4 million and purchases of treasury shares of $158.8 million.
At July 31, 2026, cash and cash equivalents were $113.4 million, compared with $108.4 million at October 31, 2025. Short-term debt was $192.0 million, current maturities of long-term debt and notes payable were $10.0 million, compared with $315.0 million, and long-term debt was $1.53 billion, compared with $1.68 billion. Total shareholders' Equity was $3.27 billion, compared with $3.04 billion, and total Assets were $5.95 billion, compared with $5.92 billion.
In January 2026, Nordson entered into a $1.20 billion senior unsecured multicurrency revolving Credit Facility maturing in January 2031. The company had zero borrowings outstanding under the facility as of July 31, 2026, and it also has a Commercial Paper program of $1.20 billion.

_11_20_2026_19_51_18_289823.jpg)




Please wait processing your request...